Association of tumor necrosis factor alpha-308 promoter polymorphism with spondyloarthritides patients in Colombia

Rheumatology International

Volumn 32, Issue 7, 2012, Pages 2195-2197

  Romero Sanchez C ^a   Londono J ^a   Delgado, G ^b   Jaimes, D A ^a   De Avila, J ^b   Mora, A ^a   Avila M ^a   Castellanos, J ^b   Briceno I ^a   Valle Onate R ^a  

^a UNIVERSIDAD DE LA SABANA   (Colombia)

^b UNIVERSIDAD EL BOSQUE   (Colombia)

Author keywords

Polymorphism; Spondyloarthritides; TNF Alpha

Indexed keywords

HLA B27 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; BLOOD SAMPLING; COLOMBIA; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; REACTIVE ARTHRITIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; SPONDYLARTHRITIS; SYMPTOM;

EID: 84863988942     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-011-1883-1     Document Type: Article

References (10)

1. Rudwaleit M, Höhler T (2001) Cytokine gene polymorphisms relevant for the spondyloarthropathies. Curr Opin Rheumatol 13:250-254 (Pubitemid 32831814)
2. Rudwaleit M, Siegert S, Yin Z, Eick J, Thiel A, Radbruch A et al (2001) Low T cell production of TNF alpha and INF gamma in ankylosing spondylitis. Its relation to HLA-B27 and influence of the TNF-308 gene polymorphism. Ann Rheum Dis 60:36-42 (Pubitemid 32038951)
3. Höhler T, Schäper T, Schneider PM, Meyer zum Buschenfelde KH, Marker-Hermann E (1998) Association of different tumor necrosis factor-promoter allele frequencies with ankylosing spondylitis in HLA-B27-positive individuals. Arthritis Rheum 41:1489
4. McGarry F, Walker R, Sturrock RD, Field M (1999) The -308.1 polymorphism in the promoter region of the tumor necrosis factor gene is associated with ankylosing spondylitis independent of HLA-B27. J Rheumatol 26:1110
5. Romero-Sanchez C, Robinson W, Tomooka BH, Londoño J, Valle-Oñate R, Huang F et al (2008) Identification of acute phase reactants and cytokines useful for monitoring infliximab therapy in ankylosing spondylitis. Clin Rheumatol 27:1429-1435
6. Correa PA, Gómez LM, Cadena J, Anaya JM (2005) Autoimmunity and tuberculosis. Opposite association with TNF polymorphism. J Rheumatol 32:219-224 (Pubitemid 40209118)
7. Wilson AG, di Giovine FS, Blakemore AI, Duff GW (1992) Single base polymorphism in the human tumor necrosis factor alpha (TNFa) gene detectable by NcoI restriction of PCR product. Hum Mol Genet 1:353
8. Vargas-Alarcon G, Casasola-Vargas J, Rodriguez-Perez JM, Huerta-Sil G, Pérez-Hernandez N, Londoño J et al (2006) Tumor necrosis factor promoter polymorphisms in Mexican patients with spondyloarthritis. Hum Immunol 67:826-832 (Pubitemid 44572596)
9. Citera G, Schneeberger E, Maldonado-Cocco JA, Anaya JM (2007) TNF-Alfa and IL-1 Beta genetic polymorphism as risk for Ankylosing Spondylitis. Confirming evidence in Argentineans. Ann Rheum Dis 66(Suppl II):387
10. Shiau MY, Lo MK, Chang CP, Yang TP, Ho KT, Chang YH (2007) Association of tumor necrosis factor a promoter polymorphism with ankylosing spondylitis in Taiwan. Ann Rheum Dis 66:562-563